Clinical Trials In Minneapolis

Discover hundreds of clinical trials in Minneapolis.
Search clinical trials in Minneapolis by condition or phase.

e.g. Respiratory Diseases

Minneapolis•Healthy volunteers: No

Filter results

Results: 1,052

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting

Phase 3

Sponsor:

AbbVie

Location:

Eagan, Flagstaff, Glendale, Peoriashow 69 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

Welcoming by Design Pilot: Reducing Structural Stigma by Changing Clinic Systems and Architectural Design

Recruiting

Sponsor:

University of Minnesota

Location:

Minneapolis

Code:

NCT05642676

Conditions

Hiv

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Clinics remodeling

EKG Criteria and Identification of Acute Coronary Occlusion

Recruiting

Sponsor:

Stony Brook University

Location:

Minneapolis, Stony Brook

Code:

NCT03863327

Conditions

Acute Coronary Syndrome

STEMI

STEMI - ST Elevation Myocardial Infarction

Acute Coronary Artery Thrombosis (Diagnosis)

NSTEMI - Non-ST Segment Elevation MI

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

No intervention

A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight

Recruiting

Phase 3

Sponsor:

Novo Nordisk A/S

Location:

Minneapolis, Escondido, New Haven, Columbusshow 17 more

Code:

NCT05726227

Conditions

Obesity

Eligibility Criteria

Sex: All

Age: 6 - 18

Healthy Volunteers: Not accepted

Interventions

Semaglutide

Placebo

CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

Recruiting

Phase 3

Sponsor:

VA Office of Research and Development

Location:

Minneapolis, Boston, New York

Code:

NCT05931276

Conditions

End-Stage Kidney Disease

End-Stage Renal Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Metoprolol Succinate

Carvedilol

The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

Recruiting

Phase 2

Sponsor:

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Location:

Minneapolis, Torrance, Brandon, Miamishow 4 more

Code:

NCT05540327

Conditions

Systemic Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

M5049 low dose

M5049 medium dose

M5049 high dose

Placebo

M5049 very high dose

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Recruiting

Phase 3

Sponsor:

United Therapeutics

Location:

Minneapolis, Rochester, Birmingham, Jaspershow 75 more

Code:

NCT04708782

Conditions

Idiopathic Pulmonary Fibrosis

Interstitial Lung Disease

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Placebo

Inhaled Treprostinil

Treprostinil Ultrasonic Nebulizer

Evaluating Treatments for Suicidal Veterans With PTSD

Recruiting

Sponsor:

VA Office of Research and Development

Location:

Minneapolis, Durham, Seattle

Code:

NCT05974631

Conditions

Self-directed Violence

Post-traumatic Stress Disorder (PTSD)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dialectical Behavior Therapy

Dialectical Behavior Therapy Prolonged Exposure protocol

Prolonged Exposure therapy

Suicide risk management

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Recruiting

Phase 3

Sponsor:

Takeda

Location:

Minneapolis, Rochester, Phoenix, Los Angelesshow 17 more

Code:

NCT04779320

Conditions

Crohn's Disease (CD)

Eligibility Criteria

Sex: All

Age: 2 - 17

Healthy Volunteers: Not accepted

Interventions

Vedolizumab IV

MILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Minneapolis, Woodbury, Waconia, Sartellshow 940 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression

e.g. Respiratory Diseases

Minneapolis•Healthy volunteers: No

Filter results

Results: 1,052

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting

Phase 3

Sponsor:

AbbVie

Location:

Eagan, Flagstaff, Glendale, Peoriashow 69 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

Welcoming by Design Pilot: Reducing Structural Stigma by Changing Clinic Systems and Architectural Design

Recruiting

Sponsor:

University of Minnesota

Location:

Minneapolis

Code:

NCT05642676

Conditions

Hiv

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Clinics remodeling

EKG Criteria and Identification of Acute Coronary Occlusion

Recruiting

Sponsor:

Stony Brook University

Location:

Minneapolis, Stony Brook

Code:

NCT03863327

Conditions

Acute Coronary Syndrome

STEMI

STEMI - ST Elevation Myocardial Infarction

Acute Coronary Artery Thrombosis (Diagnosis)

NSTEMI - Non-ST Segment Elevation MI

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

No intervention

A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight

Recruiting

Phase 3

Sponsor:

Novo Nordisk A/S

Location:

Minneapolis, Escondido, New Haven, Columbusshow 17 more

Code:

NCT05726227

Conditions

Obesity

Eligibility Criteria

Sex: All

Age: 6 - 18

Healthy Volunteers: Not accepted

Interventions

Semaglutide

Placebo

CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

Recruiting

Phase 3

Sponsor:

VA Office of Research and Development

Location:

Minneapolis, Boston, New York

Code:

NCT05931276

Conditions

End-Stage Kidney Disease

End-Stage Renal Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Metoprolol Succinate

Carvedilol

The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

Recruiting

Phase 2

Sponsor:

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Location:

Minneapolis, Torrance, Brandon, Miamishow 4 more

Code:

NCT05540327

Conditions

Systemic Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

M5049 low dose

M5049 medium dose

M5049 high dose

Placebo

M5049 very high dose

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Recruiting

Phase 3

Sponsor:

United Therapeutics

Location:

Minneapolis, Rochester, Birmingham, Jaspershow 75 more

Code:

NCT04708782

Conditions

Idiopathic Pulmonary Fibrosis

Interstitial Lung Disease

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Placebo

Inhaled Treprostinil

Treprostinil Ultrasonic Nebulizer

Evaluating Treatments for Suicidal Veterans With PTSD

Recruiting

Sponsor:

VA Office of Research and Development

Location:

Minneapolis, Durham, Seattle

Code:

NCT05974631

Conditions

Self-directed Violence

Post-traumatic Stress Disorder (PTSD)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dialectical Behavior Therapy

Dialectical Behavior Therapy Prolonged Exposure protocol

Prolonged Exposure therapy

Suicide risk management

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Recruiting

Phase 3

Sponsor:

Takeda

Location:

Minneapolis, Rochester, Phoenix, Los Angelesshow 17 more

Code:

NCT04779320

Conditions

Crohn's Disease (CD)

Eligibility Criteria

Sex: All

Age: 2 - 17

Healthy Volunteers: Not accepted

Interventions

Vedolizumab IV

MILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Minneapolis, Woodbury, Waconia, Sartellshow 940 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression